Correlation Between Protara Therapeutics and Sellas Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Sellas Life Sciences, you can compare the effects of market volatilities on Protara Therapeutics and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Sellas Life.

Diversification Opportunities for Protara Therapeutics and Sellas Life

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Protara and Sellas is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Sellas Life go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Sellas Life

Given the investment horizon of 90 days Protara Therapeutics is expected to generate 1.36 times more return on investment than Sellas Life. However, Protara Therapeutics is 1.36 times more volatile than Sellas Life Sciences. It trades about 0.25 of its potential returns per unit of risk. Sellas Life Sciences is currently generating about -0.04 per unit of risk. If you would invest  303.00  in Protara Therapeutics on August 20, 2025 and sell it today you would earn a total of  372.00  from holding Protara Therapeutics or generate 122.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Protara Therapeutics  vs.  Sellas Life Sciences

 Performance 
       Timeline  
Protara Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Sellas Life Sciences 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Sellas Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Protara Therapeutics and Sellas Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protara Therapeutics and Sellas Life

The main advantage of trading using opposite Protara Therapeutics and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.
The idea behind Protara Therapeutics and Sellas Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings